6 JULY NEW ZEALAND GAZETTE 1807

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the schedule hereto:

Schedule

Product: Medeco Paracetamol
Active Ingredient(s): Paracetamol DC90 556mg equivalent to 500mg paracetamol
Dosage Form: Coated tablet
New Zealand Sponsor: PSM Healthcare Limited
Manufacturer(s): PSM Healthcare Limited, Wiri, Auckland

Product: Panadeine Tension
Active Ingredient(s): Codeine phosphate (anhydrous) 8mg
Doxylamine succinate 5mg
Paracetamol 500mg
Dosage Form: Capsule
New Zealand Sponsor: SmithKline Beecham (NZ) Limited
Manufacturer(s): SmithKline Beecham (Australia) Pty Limited, Dandenong, Victoria, Australia
SmithKline Beecham (Australia) Pty Limited, Ermington, New South Wales, Australia

Product: Visine True Tears Multidose Eye Drops
Active Ingredient(s): Macrogol 400 1%w/v
Glycerol 0.2%v/v
Hypromellose 0.2%w/v
Dosage Form: Eye drops, solution
New Zealand Sponsor: Pfizer Laboratories Limited
Manufacturer(s): Pfizer Inc, Parsippany, New Jersey, United States of America

Dated this 30th day of June 2000.

G. R. BOYD,
Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go4857

Classification of Medicines

Pursuant to section 106(1) of the Medicines Act 1981, I, G. R. Boyd, Chief Advisor, Safety and Regulation, acting under delegated authority, hereby declare the following:

1. The medicines listed in Schedule 1 to this notice are classified as prescription medicines.
2. The medicines listed in Schedule 2 to this notice are classified as restricted medicines.
3. The medicines listed in Schedule 3 to this notice are classified as pharmacy-only medicines.

Every reference to a medicine in this notice applies whether the medicine is synthetic in origin or is from biological or mineral sources.

Unless specific reference is made otherwise, every reference applies also to medicines that are:
(a) Preparations and admixtures containing any proportion of any substance listed in the notice;
(b) Salts and esters of any substance listed in the notice;
(c) Preparations or extracts of biological materials listed in the notice;
(d) Salts or oxides of elements listed in the notice.

Where any reference is modified by a statement of the strength of the medicine, the strength is calculated using the free acid, base, alcohol or element unless specifically stated otherwise.

Schedule 1

Prescription Medicines

abacavir
alkyl sulfonals
amphomycin
androisoxazole
azelaic acid; except for dermal use
bicalutamide
bolandiol
bolasterone
bolazine
boldenone (dehydrotestosterone)
bolenol
bolmantalate
butylchloral hydrate
4-chloromethandienone
calusterone
candicidin
captopriame
capuride
cefacloride
cefaloridine
cefapirin
chloralamide
chloralformamide
chloral hydrate; except in topical preparations containing 2% or less
chloralose
chlorandrostenolone
chloroform; for use in anaesthesia; except when specified elsewhere in the Schedules
chloroxymesterone (dehydrochloromethyltestosterone)
clocortolone
clofenamide
clomocyeline
clostebol (4-chlorotestosterone)
corticosterone